S&P 500 Faces Sixth Consecutive Decline Amid AI Sector Volatility and Johnson & Johnson Product Advancements

The S&P 500 is on track for its sixth straight session of declines, dropping approximately 7% from its October record high. Market volatility was exacerbated by a sharp decline in Anthropic shares following an initial surge, which negatively impacted the broader AI-themed sector. Despite the downturn, some sectors like cybersecurity showed resilience following strong earnings from Palo Alto Networks and news regarding cyberattacks at JPMorgan Chase service providers. In healthcare, Johnson & Johnson (J&J) reported significant progress with its Ottava robotic surgical system, which will see its first commercial installation at Memorial Hermann-Texas Medical Center. Additionally, J&J has submitted its antipsychotic drug Caplyta to the FDA for bipolar mania treatment. While J&J shares have faced recent pressure due to a slowdown in healthcare rotation, the company's pharmaceutical growth remains a key long-term driver.

By Natasha Abellard,Jeff Marks · CNBC ·

S&P 500 Faces Sixth Consecutive Decline Amid AI Sector Volatility and Johnson & Johnson Product Advancements

Tickers: $CRWD $FDX $JNJ $JPM $META $PANW $STZ

Topics: AI Sector Cybersecurity Robotic Surgery Stock Market Performance

Read the full article at CNBC

Part of the story WELLS FARGO & COMPANY/MN - 4 Filing (1854 articles)

More World news